Association of transforming growth factor-β1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection (original) (raw)
Abstract
Transforming growth factor-β1 (TGF-β1) can act as both a tumor suppressor and a stimulator of tumor progression. We have examined the relationship between polymorphisms of the TGF-β1 gene and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection. A total of 1,237 Korean subjects were prospectively enrolled; 1,046 patients with chronic HBV infection and 191 healthy controls with no evidence of recent or remote HBV infection. The patients were divided into two groups: those without (n=809) and those with HCC (n=237). Single nucleotide polymorphisms (SNPs) of TGF-β1 were searched for and genotyped using the single base extension method. In Korean subjects, only two SNPs were found among the seven known polymorphisms of TGF-β1, at position -509 and in codon 10. The risk of HCC was significantly lower in patients with the T/T or C/T genotypes than in those with the C/C genotypes at position -509 (P<0.02), and also lower among those with the Pro/Pro or Leu/Pro genotypes than in those with the Leu/Leu genotypes in codon 10 (P<0.007). Haplotype analysis revealed that the possession of [-509C>T; L10P] conferred a decreased likelihood of HCC (OR=0.74; 95% CI, 0.59-0.93; P=0.008). In conclusion, the presence of the TGF-β1 -509C>T promoter or of the L10P polymorphism, and the combination of both [-509C>T; L10P] as a haplotype were strongly associated with a reduced risk of HCC in patients with chronic HBV infection.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, 110-744, Korea
Yoon Jun Kim
Authors
- Yoon Jun Kim
- Hyo-Suk Lee
- Jong Pil Im
- Byung-Hoon Min
- Hyun Dae Kim
- Ji Bong Jeong
- Jung-Hwan Yoon
- Chung Yong Kim
- Myung Soo Kim
- Jun Yeon Kim
- Ji Hyun Jung
- Lyoung Hyo Kim
- Byung Lae Park
- Hyoung Doo Shin
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
This article is cited by
No association between TGF-β1 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control study
- Wafa Khaali
- Khalid Moumad
- Meriem Khyatti
BMC Medical Genetics (2016)
Association of TGF-β1 -509C/T polymorphisms with breast cancer risk: evidence from an updated meta-analysis
- Yadong Wang
- Xinwei Chu
- Fei Zou
Tumor Biology (2014)
Polymorphisms of VEGF, TGFβ1, TGFβR2 and conotruncal heart defects in a Chinese population
- Enshi Wang
- Zhenhua Wang
- Hao Zhang
Molecular Biology Reports (2014)
TGF-β1 −509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk
- Weixing Li
- Han Wu
- Chao Song
Tumor Biology (2013)
TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model
- Guo-Cai Li
- Qing-Hai Ye
- Lun-Xiu Qin
Journal of Experimental & Clinical Cancer Research (2012)